D Sosnowska 1 , K Dzierzbicka , A Myśliwski , A M Kołodziejczyk
1. Katedra i Zakład Histologii Akademii Medycznej, Gdańsku.
Published:
GICID: 01.3001.0000.2787
Available language versions: en pl
Issue: Postepy Hig Med Dosw 1992; 46 (5)
Abstract
This paper presents a review of studies on the metabolism, pharmacological and clinical properties of a new synthetic muramyl dipeptide derivative N2-/(N-acetylmuramoyl)-L-alanyl-D-isoglutaminyl/-N6-stearoyl-L-lysine(MD P- Lys(L18), muroctasin). Due to its effect on the number of peripheral blood leukocytes this compound is expected to be a useful drug for the treatment of leukopenia induced by cancer chemotherapy or radiation therapy.